Skip to main content
Log in

Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of δ and μ opioid receptors

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

We have previously (Daugé et al. 1988) demonstrated that injection of the μ agonist [d-Ala2, MePhe4, Gly-ol5]-enkephalin (DAGO) or the δ agonist [d-Thr2, Leu5]-enkephalyl-Thr6 (DTLET) into the rat Nucleus accumbens (N.Acc.), or Nuceeus caudatus (N.Caud.) induced a hypoactivity followed by hyperactivity 150 min later in the case of the μ agonist and a hyperactivity in the case of the δ agonist. Moreover, naloxone reversible delta-type responses were obtained by local infusion of kelatorphan, ([(R)-3(N-hydroxylcarboxamido-2-benzylpropanoyl)-l-alanine]), a complete inhibitor of enkephalin catabolism, suggesting a tonic control of the behavioral activity of rat by the endogenous opioid peptides. In this work, the putative involvement of the dopaminergic system in these behavioral responses was investigated by using the DA antagonist thioproperazine. In the N.Acc., the behavioral effects of kelatorphan, or of μ or δ agonists were not altered by thioproperazine-induced blockade of dopamine receptors. In contrast, the hyperactivity produced by DTLET or by kelatorphan in the N.Caud. was reversed by thioproperazine while the time-dependent biphasic effect resulting from DAGO injection remained unaffected by the DA antagonist. This blocking effect of thioproperazine is in agreement with the previously described δ-selective enhancement of the release of newly synthesized DA in the striatum but not in the N.Acc.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Algeri S, Brunello N, Calderini G, Consolazione A (1978) Effect of enkephalins on catecholamine metabolism in rat CNS. Adv Biochem Psychopharmacol 18:199–209

    Google Scholar 

  • Atweh SF, Kuhar MJ (1977) Autoradiographic localization of opiate receptors in rat brain, II. The brainstem. Brain Res 129:1–12

    Google Scholar 

  • Biggio GH, Carn M, Corda G, Dibello C, Gessa GL (1978) Stimulation of dopamine synthesis in caudate nucleus by intrastriatal enkephalins and antagonism by naloxone. Science 200:552–554

    Google Scholar 

  • Bourgoin S, Le Bars D, Artaud F, Clot AM, Bouboutou R, Fournié-Zaluski MC, Roques BP, Hamon M, Cesselin F (1986) Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of Met-enkephalin-like material from the rat spinal cord. J Pharmacol Exp Ther 238:360–366

    Google Scholar 

  • Bozarth MA, Wise RA (1981) Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 28:551–555

    Google Scholar 

  • Britt MD, Wise RA (1983) Ventral tegmental site of opiate reward: antagonism by a hydrophilic opiate receptor blocker. Brain Res 258:105–108

    Google Scholar 

  • Chesselet MF, Cheramy A, Reisine TD, Lubetzki C, Glowinski J, Fournié-Zaluski MC, Roques BP (1982) Effects of various opiates including specific delta and mu agonist dopamine release from nigrostriatal dopaminergic neurons in vitro in the cat. Life Sci 31:2291–2294

    Google Scholar 

  • Costa E, Cheney DL, Racagni G, Zsilla G (1975) An analysis at synaptic level of the morphine action in striatum and N. accumbens: dopamine and acetylcholine interactions. Life Sci 17:1–8

    Google Scholar 

  • Cotton R, Giles MG, Miller L, Show JS, Timms D (1984) ICI 174,864: a highly selective antagonist for the opioid δ receptor. Eur J Pharmacol 97:331–332

    Google Scholar 

  • Cowan A, Zhu XZ, Mosberg HI, Omnas JR, Porreca F (1988) Direct dependence studies in rats with agents selective for different types of opioid receptors. J Pharmacol Exp Ther 246:950–955

    Google Scholar 

  • Daugé V, Rossignol P, Roques BP (1988) Comparison of the behavioral effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective μ and δ opioid peptides or kelatorphan, an inhibitor of enkephalin-degrading-enzymes. Psychopharmacology 96:343–352

    Google Scholar 

  • Delay-Goyet P, Zajac JM, Rigaudy P, Foucaud F, Roques BP (1985) Comparative binding properties of linear and cyclic δ-selective enkephalin analogues: [3H]-[d-Thr2, Leu5]enkephalyl-Thr6 and [3H]-[d-Pen2, d-Pen5]enkephalin. FEBS Lett 183:439–443

    Google Scholar 

  • Dickenson AH, Sullivan A, Fournié-Zaluski MC, Roques BP (1987) Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurons in rat spinal cord. Brain Res 408:185–191

    Google Scholar 

  • Eghbali M, Santoro C, Paredes W, Gardner EL, Zukin RZ (1987) Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions. Proc Natl Acad Sci USA 84:6582–6586

    Google Scholar 

  • Fournié-Zaluski MC, Chaillet P, Bouboutou R, Coulaud A, Cherot P, Waksman G, Costentin J, Roques BP (1984) Analagsic effects of kelatorphan, a new highly potent inhibitir of multiple enkephalin degrading enzymes. Eur J Pharmacol 102:525–528

    Google Scholar 

  • Goeders NE, Lane LD, Smith JW (1984) Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav 20:451–455

    Google Scholar 

  • Hand TM, Franklin KB (1985) 6 OH-DA lesions of the ventral tegmental area block morphine-induced but not amphetamine-induced facilitation of self-administration. Brain Res 328:233–241

    Google Scholar 

  • Handa BK, Lane AC, Lord JAH, Morgan BA, Rance MJ, Smith CFC (1981) Analogues of beta-LPH 61-64 possessing selective agonists of mu-opiate receptors. Eur J Pharmacol 70:531–540

    Google Scholar 

  • Iwamota ET, Way LE (1977) Circling behavior and stereotypy induced by intranigral opiate microinjections. J Pharmacol Exp Ther 203:347–359

    Google Scholar 

  • Johnson RP, Sar M, Stumpf WE (1980) A topographic localization of enkephalin on the dopamine cyclase activity in rat striatum. Abstract Society of Neuroscience 14th Annual Meeting Anaheim CA: 10-15

  • Johnson RP, Sar M, Stumpf WE (1981) A topographic localization of enkephalin on the dopamine neurons of the rat substantia nigra and ventral tegmental area demonstrated by combined histofluorescence-immuno-histochemistry. Brain Res 194:566–571

    Google Scholar 

  • Joyce EM, Koob GF, Strecker R, Iversen SD, Bloom FE (1981) The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus. Brain Res 221:359–370

    Google Scholar 

  • Kalivas PW (1985) Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci Biobehav Res 9:573–587

    Google Scholar 

  • Kalivas PW, Bronson M (1985) Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin. Neuropharmacology 24:931–936

    Google Scholar 

  • Kalivas PW, Richardson-Carlson R (1986) Endogenous enkephalin modulation of dopamine neurons in the ventral tegmental area. Am J Physiol 251:R243-R249

    Google Scholar 

  • Kalivas PW, Widerlöv E, Stanley D, Breese G, Prange AJ Jr (1983) Enkephalin action on the mesolimbic system. A dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 227:229–237

    Google Scholar 

  • Kalivas PW, Richardson-Carlson R, Van Orden G (1986) Cross-sensitization between footshock stress and enkephalin-induced motor activity. Biol Psychiatry 21:939–950

    Google Scholar 

  • Kelley AE, Stinus L, Iversen SD (1980) Interactions between D.Ala-Met-enkephalin, A10 dopaminergic neurons and spontaneous behavior in the rat. Behav Brain Res 1:3–24

    Google Scholar 

  • Lubetki C, Chesselet MF, Glowinski J (1982) Modulation of dopamine release in rat striatal slices by delta opiate agonists. J Pharmacol Exp Ther 222:435–440

    Google Scholar 

  • MacLennon AJ, Maier SF (1983) Coping and the stress-induced potentiation of stimulant stereotypy in the rat. Science 219:1091–1093

    Google Scholar 

  • Matsumoto RR, Brinsfield KH, Patrick RL, Walker JM (1988) Rotational behavior mediated by dopaminergic and non-dopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. J Pharmacol Exp Ther 246:196–203

    Google Scholar 

  • Mauborgne A, Lutz O, Legrand J-C, Hamon M, Cesselin F (1987) Opposite effects of δ and μ opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord. J Neurochem 48:529–537

    Google Scholar 

  • Moskowitz AS, Goodman R (1984) Light microscopic autoradiographic localization of μ and δ opioid binding sites in the mouse central nervous system. J Neurosci 4:1331–1342

    Google Scholar 

  • Mulder AH, Wardeh G, Hogenboom F, Frankhuyzen AL (1984) κ and δ opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278–280

    Google Scholar 

  • Nabeshima T, Katoh A, Hiramatsu M, Kameyama T (1986) A role played by dopamine and opioid neuronal systems in stress-induced motor suppression (conditioned suppression of motility) in mice. Brain Res 398:354–360

    Google Scholar 

  • Paxinos G, Watson C (1982) The rat brain. Academic Press, NY

    Google Scholar 

  • Pert A, Sivit C (1977) Neuroanatomical focus for morphine and enkephalin-induced hypermotility. Nature 265:645–647

    Google Scholar 

  • Petit F, Hamon M, Fournié-Zaluski MC, Roques BP, Glowinski J (1986) Further evidence for a role of delta opiate receptors in the presynaptic regulation of newly synthesized dopamine release. Eur J Pharmacol 126:1–9

    Google Scholar 

  • Phillips AG, Le Piane FG (1980) Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav 12:965–968

    Google Scholar 

  • Phillips AG, Le Piane FG (1982) Reward produced by microinjection of (d-Ala)-Met-enkephalinamide into the ventral tegmental area. Behav Brain Res 5:225–229

    Google Scholar 

  • Phillips AG, Le Piane FG, Fibiger HC (1983) Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area. Life Sci 33:2505–2511

    Google Scholar 

  • Pijnenburg AJJ, Honig WMM, Vanderheyden JAM, Van Rossum JM (1976) Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45–58

    Google Scholar 

  • Pollard H, Llorens-Cortes C, Bennett JJ, Costentin J, Schwartz JC (1977) Opiate receptors on mesolimbic dopaminergic neurons. Neurosci Lett 7:295–299

    Google Scholar 

  • Roques BP, Fournié-Zaluski MC, Soroca E, Lecomte JM, Malfroy B, Llorens C, Schwartz JC (1980) The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 288:286–288

    Google Scholar 

  • Roques BP, Daugé V, Gacel G, Fournié-Zaluski MC (1985) Selective agonists and antagonists of delta opioid receptors and inhibitors of enkephalins metabolism. Potential use in treatment of mental illness. Biol Psychiatry 7:287–289

    Google Scholar 

  • Scott Young III W, Bonner TI, Brann MR (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83:9827–9831

    Google Scholar 

  • Shippenberg TS, Bals-Kubrik R, Herz A (1987) Motivational properties of opioids: evidence that an activation of δ-receptors mediates reinforcement processes. Brain Res 436:234–239

    Google Scholar 

  • Stachura ME (1976) Basal and dibutyryl cyclic AMP-stimulated release of newly synthesized and stored growth hormone from perfused rat pituitaries. Endocrinology 98:580

    Google Scholar 

  • Stinus L, Koob GF, Ling N, Bloom FE, Le Moal M (1980) Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc Natl Acad Sci USA 77:2323–2327

    Google Scholar 

  • Stinus L, Winnock MR, Kelley AE (1985) Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioral supersensitivity to opiates. Psychopharmacology 85:323–328

    Google Scholar 

  • Stinus L, Nadaud D, Jauregui J, Kelly AE (1986) Chronic treatment with five different neuroleptics elicits behavioral hypersensitivity to opiate infusion into the nucleus accumbens. Biol Psychiatry 21:34–48

    Google Scholar 

  • Waksman G, Bouboutou R, Devin J, Bourgoin S, Cesselin F, Hamon M, Fournié-Zaluski MC, Roques BP (1985) In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Eur J Pharmacol 117:233–243

    Google Scholar 

  • Waksman G, Hamel E, Delay-Goyet P, Roques BP (1987) Neutral endopeptidase-24.11, mu and delta opioid receptors after selective brain lesions: an autoradiographic study. Brain Res 436:205–216

    Google Scholar 

  • White JD, Stewart KD, Krause JE, Mekevy JF (1985) Biochemistry of peptide-secreting neurons. Physiol Rev 65:553–606

    Google Scholar 

  • Wilcox RE, Bozarth M, Levitt RA (1983) Reversal of morphine-induced catalepsy by naloxone microinjections into brain regions with high opiate receptor binding: a preliminary report. Pharmacol Biochem Behav 18:51–54

    Google Scholar 

  • Wood PL, Stotland M, Richard JW, Rackham A (1980) Action of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J Pharmacol Exp Ther 215:697–703

    Google Scholar 

  • Zajac JM, Gacel G, Petit F, Dodey P, Rossignol P, Roques BP (1983) Deltakephalin, Tyr-d-Thr-Gly-Phe-Leu-Thr: a new highly potent and fully specific agonist for opiate delta receptors. Biochem Biophys Res Commun 111:390–397

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daugé, V., Rossignol, P. & Roques, B.P. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of δ and μ opioid receptors. Psychopharmacology 99, 168–175 (1989). https://doi.org/10.1007/BF00442803

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442803

Key words

Navigation